[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100461215":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":18,"responsibleParty":38,"collaborators":7,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":44,"acronym":7,"eligibilityCriteria":45,"healthyVolunteers":42,"sex":46,"minAge":47,"maxAge":48,"enrollmentInfo":49,"targetDuration":52,"studyType":53,"phases":7,"briefSummary":54,"conditions":55,"keywords":58,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":70},{"fullName":5,"class":6},"Amivas Inc.","INDUSTRY",null,[9],{"name":10,"affiliation":5,"role":11},"Bryan Smith, MD","PRINCIPAL_INVESTIGATOR",[13],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Katrina Riggs","CONTACT","3017622609","kriggs@fastttrackresearch.com",[19],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"4C Pharma Solutions","RECRUITING","Piscataway","New Jersey","08854","United States","US",{"type":28,"coordinates":29},"Point",[30,31],-74.39904,40.49927,{"lat":31,"lon":30},[34],{"name":35,"role":15,"phone":36,"phoneExt":7,"email":37},"Ankur Joshi","732-529-6989","ankur.joshi@4cpharma.com",{"type":39,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100461215","observational-study-of-the-safety-of-intravenous-artesunate-treatment-of-pregnant-women-and-their-infants-100461215",false,"NCT05285735","Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants","Inclusion Criteria:\n\n* Patient received IV Artesunate\n* Patient was pregnant while receiving IV Artesunate\n* Patient was at least 15 years of age\n* Patient or legal guardian\u002Frepresentative gave consent for the study and to collect data from her physicians\n\nExclusion Criteria\n\n• None","FEMALE","15 Years","100 Years",{"count":50,"type":51},25,"ESTIMATED","21 Months","OBSERVATIONAL","This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child's pediatrician, or other relevant healthcare provider.",[56,57],"Pregnancy","Malaria",[59,60],"Artesunate","Pregnancy Registry","2024-01-29",{"date":63,"type":64},"2024-01-30","ACTUAL",{"date":66,"type":64},"2022-06-08",{"date":68,"type":51},"2029-07-01",{"name":5,"class":6},1]